Overview: In the last 15 years, deaths due to opioids (both prescription and heroin) have quadrupled in the United States. Opioid misuse amounts to billions of dollars in health care costs and lost wages every year. Several state governors have declared a public health emergency due to the devastating impact opioid abuse is having on communities.
Findings from data can be instrumental in creating an intervention policy that seeks to better inform health care practitioners of potential risk factors and warning signs of opioid abuse, thereby enabling targeted prevention efforts of individuals deemed to be at greatest risk.
This webinar will discuss:
Director, Field Medical Strategy
Dr. Strouss received her Bachelor of Science degree and Doctor of Pharmacy degree from the University of Pittsburgh. She is currently the Director for Field Medical Strategy at ODH, Inc. where she leads clinical strategy with emphasis in pharmacy analytics.
She has 10+ years in neuroscience scientific affairs; 10+ years in health care management with 4 years as Director of Pharmacy Research and Outcomes for Managed Care Organization. Her experience includes pharmacy clinical practice with emphasis on psychiatric medicine and physician interaction, collaboration with internal and external stakeholders within managed care organization and serving as a bridge between the two from a clinical and scientific perspective, educating accounts on clinical therapeutics presentation, medical writing, and clinical management in managed care.
Dr Strouss’ private sector experiences include development of innovative strategies for pharmacy cost management within Medicaid managed care industry, scientific liaison experience within the behavioral health MCO with emphasis on fostering relationships with key opinion leaders, integration with clinical development and assistance in site identification and education for Pennsylvania Medication Algorithm Project. Serve on Pharmacy and Therapeutics Committee specific duties include policy development and review; editing and development of the health plan drug formularies specific to behavioral health medications; evidence based review of clinical pharmacy literature with provision of clinical recommendations to P&T Committee; and development and implementation of various clinically appropriate and cost-effective clinical management strategies. Oversight of behavioral clinical pharmacist staff; interaction with state agencies for approval and implementation of formulary management policies.
Dr. Strouss is a member of International Society of Pharmacoeconomics Research (ISPOR) Patient-Reported Outcomes as well as ISPOR Clinician Reported Outcomes Good Measurement Practices. She serves on the Allegheny County Medical Response Team and is an adjunct clinical instructor at the University of Pittsburgh School of Pharmacy.
Senior Manager, Analytics & Medical Informatics
Ayan is a digital health practitioner, specializing in machine learning and data modeling. He heads the Data Science and Advanced Analytics Division at ODH. In this role he has spearheaded several new and innovative population health and analytics offerings (e.g. Behavioral Health Risk Adjustment, Population Risk Stratification and Impactability and Social Factors Risk).
He received his PhD from UMass and had a joint post-doctoral appointment at UMass and MIT. Prior to working at ODH, he was an investigator at Verisk Analytics studying environmental determinants. He has research awards from NASA and Department of Energy, and was on the Honor Roll of the President of India for his scholarly work. He has written over 20 articles in peer-reviewed journals and co-authored 2 books.